Published in the journal Clinical Cancer Research (1), preliminary results of a two-part, phase I first-in-human study show encouraging antitumor…
UITM
In an invited viewpoint article published in the Cancer Discovery, co-authors Elena Garralda, Executive Director of VHIO’s Research Unit for…
Preliminary results from a phase I clinical trial show that the first in class MYC inhibitor Omomyc (OMO-103) has few…
In her latest ESMO perspectives On target column: Multidisciplinary Tumor Boards in harmony: mission impossible?, VHIO’s Elena Garralda, Principal Investigator…
